KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Return on Sales (2016 - 2025)

Gilead Sciences' Return on Sales history spans 17 years, with the latest figure at 0.32% for Q4 2025.

  • For Q4 2025, Return on Sales rose 8.0% year-over-year to 0.32%; the TTM value through Dec 2025 reached 0.3%, up 28.0%, while the annual FY2025 figure was 0.29%, 27.0% up from the prior year.
  • Return on Sales reached 0.32% in Q4 2025 per GILD's latest filing, down from 0.39% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.39% in Q3 2025 to a low of 0.62% in Q1 2024.
  • Average Return on Sales over 5 years is 0.18%, with a median of 0.23% recorded in 2022.
  • Peak YoY movement for Return on Sales: skyrocketed 89bps in 2021, then plummeted -78bps in 2024.
  • A 5-year view of Return on Sales shows it stood at 0.05% in 2021, then soared by 326bps to 0.22% in 2022, then dropped by -10bps to 0.2% in 2023, then increased by 18bps to 0.24% in 2024, then surged by 35bps to 0.32% in 2025.
  • Per Business Quant, the three most recent readings for GILD's Return on Sales are 0.32% (Q4 2025), 0.39% (Q3 2025), and 0.28% (Q2 2025).